张志平, 姜冠潮, 王俊. 小分子干扰RNA特异性抑制人胰腺癌细胞株PANC-1突变型K-ras基因表达的探讨[J]. 中国肿瘤临床, 2006, 33(19): 1081-1084.
引用本文: 张志平, 姜冠潮, 王俊. 小分子干扰RNA特异性抑制人胰腺癌细胞株PANC-1突变型K-ras基因表达的探讨[J]. 中国肿瘤临床, 2006, 33(19): 1081-1084.
Zhang Zhiping, Jiang Guanchao, Wang Jun. The Study of Specific Inhibition of Mutant K-ras Gene Expression by Short Interfering RNAs in Human Pancreatic Carcinoma Cell PANC-1[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 33(19): 1081-1084.
Citation: Zhang Zhiping, Jiang Guanchao, Wang Jun. The Study of Specific Inhibition of Mutant K-ras Gene Expression by Short Interfering RNAs in Human Pancreatic Carcinoma Cell PANC-1[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 33(19): 1081-1084.

小分子干扰RNA特异性抑制人胰腺癌细胞株PANC-1突变型K-ras基因表达的探讨

The Study of Specific Inhibition of Mutant K-ras Gene Expression by Short Interfering RNAs in Human Pancreatic Carcinoma Cell PANC-1

  • 摘要: 目的:研究小分子干扰RNA(smallinterferingRNA,siRNA)对人胰腺癌细胞株PANC-1中突变型K-ras基因表达的抑制作用。方法:构建真核表达载体pSilencer3.1-K-rasv12,转染PANC-1细胞后应用RT-PCR及Westernblot检测突变型K-ras基因mRNA及蛋白质表达变化;噻唑蓝(MTT)测定细胞生长曲线;流式细胞仪测定细胞凋亡率。结果:测序证实siRNA真核表达载体构建成功。RT-PCR光密度比值结果空载体组、阴性对照组、实验组分别为:95.3%±2.5%、97.6%±2.8%、40.1%±3.1%,差异有统计学意义(P<0.05);Westernblot灰度比值结果空载体组、阴性对照组、实验组分别为:96.1%±2.2%、98.5%±2.0%、36.5%±3.2%,差异有统计学意义(P<0.05);实验组细胞生长受到明显抑制,凋亡率较对照组明显升高(P<0.05)。结论:pSilencer3.1-K-rasv12能有效抑制突变型K-ras基因在人胰腺癌细胞株PANC-1中的表达,抑制细胞生长,诱导细胞凋亡,为肿瘤的生物学治疗提供了新的方法。

     

    Abstract: Objective: To study the specific inhibition effect of short interfering RNAs(siRNA) on the mutant K-ras gene expression in PANC-1 cells. Methods: One pair of 63bp reverse repeated sequence targeting mutant K-rasv12 mRNA were synthesized and inserted into plasmid pSilencer3.1 eukaryotic expression vector. After transfection into PANC-1 cells, the expression of K-ras gene was detected using RT-PCR and Western blot techniques. The effect of cell proliferation was studied by MTT test. Flow cytometry was used to detect the apoptosis of transfected cells. Results: The recombinant plasmid pSilencer3.1-K-rasv12 was successfully constructed by the sequencing. The introduction of pSilencer3.1-K-rasv12 was showed to efficiently and specifically inhibit the expression of K-rasv12 gene according to the results of RT-PCR and Western blot, and there was a significant difference between the siRNA transfected group and the control groups (P<0.05). The inhibitory action on cell proliferation was confirmed by MTT test. The apoptotic rate of the pSilencer3.1-K-rasv12 group was significantly higher than that of the control groups (P<0.05). Conclusion: The siRNA targeting mutant K-ras mRNA can specially suppress the expression of mutant K-ras gene in PANC-1 cells and it provides a new method and material to the biological therapy of cancer.

     

/

返回文章
返回